In 1957, Roche introduced the class of tranquilizers known as benzodiazepines, which count valium and rohypnol as its most widely recognised members. The desired effect of these benzodiazepines ...

Valium (diazepam) was brought to the market by Roche in 1963, followed by the introduction of the monoamine oxidase inhibitor (MAOI) class of anti-depressants and antipsychotic haloperidol.

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...